ATE88888T1 - Gemfibrozil enthaltende mittel mit verlaengerter freigabe. - Google Patents

Gemfibrozil enthaltende mittel mit verlaengerter freigabe.

Info

Publication number
ATE88888T1
ATE88888T1 AT90102021T AT90102021T ATE88888T1 AT E88888 T1 ATE88888 T1 AT E88888T1 AT 90102021 T AT90102021 T AT 90102021T AT 90102021 T AT90102021 T AT 90102021T AT E88888 T1 ATE88888 T1 AT E88888T1
Authority
AT
Austria
Prior art keywords
gemfibrozil
extended release
release agents
containing extended
granulation
Prior art date
Application number
AT90102021T
Other languages
English (en)
Inventor
Isaac Ghebre-Sellassie
Mahdi Fawzi
Uma Iyer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE88888T1 publication Critical patent/ATE88888T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90102021T 1989-02-02 1990-02-01 Gemfibrozil enthaltende mittel mit verlaengerter freigabe. ATE88888T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,083 US4925676A (en) 1989-02-02 1989-02-02 Extended release gemfibrozil composition

Publications (1)

Publication Number Publication Date
ATE88888T1 true ATE88888T1 (de) 1993-05-15

Family

ID=23179257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90102021T ATE88888T1 (de) 1989-02-02 1990-02-01 Gemfibrozil enthaltende mittel mit verlaengerter freigabe.

Country Status (20)

Country Link
US (1) US4925676A (de)
EP (1) EP0381218B1 (de)
JP (1) JPH02235810A (de)
CN (1) CN1044590A (de)
AT (1) ATE88888T1 (de)
AU (1) AU624217B2 (de)
CA (1) CA2009134A1 (de)
DE (1) DE69001487T2 (de)
DK (1) DK0381218T3 (de)
ES (1) ES2055176T3 (de)
FI (1) FI900492A7 (de)
HU (1) HU204194B (de)
IE (1) IE900372L (de)
IL (1) IL92995A0 (de)
MY (1) MY104899A (de)
NO (1) NO900483L (de)
NZ (1) NZ232322A (de)
PH (1) PH26308A (de)
PT (1) PT93028A (de)
ZA (1) ZA90778B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
EP0462066A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphes Gemfibrozil
EP0475894A1 (de) * 1990-08-27 1992-03-18 Warner-Lambert Company Verbesserte Gemfibrozil-Formulierungen
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
EP0614358A1 (de) * 1991-11-26 1994-09-14 Warner-Lambert Company Verfahren und zusammensetzung für die entwicklung einer gemfibrozil dosierungsform mit kontrollierter freigabe
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) * 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
EP1572190B1 (de) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
EP1753398B1 (de) * 2004-06-10 2018-09-19 Glatt Air Techniques, Inc. Pharmazeutische darreichungsformulierung mit kontrollierter freisetzungsmatrix

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
AU1422388A (en) * 1987-01-27 1988-08-10 Warner-Lambert Company Lipid regulating compositions

Also Published As

Publication number Publication date
PT93028A (pt) 1990-08-31
PH26308A (en) 1992-04-29
ZA90778B (en) 1991-10-30
EP0381218B1 (de) 1993-05-05
HUT52952A (en) 1990-09-28
IL92995A0 (en) 1990-09-17
NO900483D0 (no) 1990-02-01
HU900640D0 (en) 1990-04-28
NZ232322A (en) 1991-02-26
IE900372L (en) 1990-08-02
DE69001487D1 (de) 1993-06-09
NO900483L (no) 1990-08-03
CN1044590A (zh) 1990-08-15
ES2055176T3 (es) 1994-08-16
AU624217B2 (en) 1992-06-04
AU4899090A (en) 1990-08-09
US4925676A (en) 1990-05-15
FI900492A7 (fi) 1990-08-03
MY104899A (en) 1994-06-30
EP0381218A2 (de) 1990-08-08
JPH02235810A (ja) 1990-09-18
FI900492A0 (fi) 1990-01-31
DK0381218T3 (da) 1993-06-01
EP0381218A3 (en) 1990-12-05
HU204194B (en) 1991-12-30
CA2009134A1 (en) 1990-08-02
DE69001487T2 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
ATE88888T1 (de) Gemfibrozil enthaltende mittel mit verlaengerter freigabe.
FR2685869B1 (fr) Compositions therapeutiques a base d'inhibiteurs mixtes de la no synthase et de la cyclooxygenase.
NO902703D0 (no) Nye o-(3-amino-2-hydroxypropyl)-hydroximinsyrehalogeniderog fremgangsmaate for fremstilling av disse.
KR910000107U (ko) 슬라이드 파스너의 해제를 저지하는 장치
ATE59967T1 (de) Tierstreu.
ATE122880T1 (de) Mehrfach teilbare tablettenstruktur.
DK180389A (da) Fremgangsmaade til desinfektion af lokaler samt anlaeg til udoevelse af fremgangsmaaden
IT1229531B (it) Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
NO883416D0 (no) Innretning for dynamisk tverrfeste av foten.
IT8921898A0 (it) Procedimento e dispositivo per l'applicazione di fascette su confezioni.
FI850126L (fi) Foerfarande foer framstaellning av vattenloesliga polymerer.
FR2624012B1 (fr) Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
NO884018D0 (no) Fremgangsmaate for fremstilling av en friradikaladdisjonspolymer.
BE856849A (fr) Composition pharmaceutique a base d'organophosphate et de sulfoxyde
AU558587B2 (en) Antiinflammatory composition of inositol and piroxicam
DE3861938D1 (de) Kombinierte kupplungs- und bremsvorrichtung.
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
NO893326L (no) Fremgangsmaate for noeytralisering av svovelsyre inneholdende sinkioner.
NO933235D0 (no) Anvendelse av en inhibitor for fremstilling av et medikament
NZ217489A (en) Pharmaceutical composition of ace inhibitor and a loop diuretic and the combination product of these two agents
NO905063L (no) Fremgangsmaate for fremstilling samt anvendelse av pyridin-2-4- og 2,5- dikarboksylsyrediamider.
FR2577804B1 (fr) Compositions pharmaceutiques a base de verapamil et d'alfuzosine
KR890019108U (ko) 클러치 겸용 가속 페달
FR2577803B1 (fr) Compositions pharmaceutiques a base de nifedipine et d'alfuzosine
IT1223097B (it) Formulazione farmaceutica contenente gemfibrozil microincapsulato